Skip to main content

Pipecuronium Bromide (Arduan)

  • Chapter
New Neuromuscular Blocking Agents

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 79))

Abstract

Muscle relaxants belong to the basic anesthetic drugs and it is quite understandable that newer compounds have come into being. Among these drugs, steroid derivatives have an important place and, besides pancuronium, many similarly structured muscle relaxants have been tried in the past few years (Sugrue et al. 1975; Bowman 1980; Tuba 1980).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alánt O, Darvas K, Pulay I (1980) First clinical experience with a new neuromuscular blocker pipecuronium bromide. Arzneimittelforsch 20:374–379

    Google Scholar 

  • Alyantdin RN, Buyanon VV, Fisenco VP, Lemina E, Muratov VK, Samoilov DN, Shorr VA (1980) On some properties of a new steroidal curare-like compound pipecuronium bromide. Arzneimittelforsch 30:355–357

    Google Scholar 

  • Barankay A (1980) Circulatory effects of pipecuronium bromide during anesthesia of patients with severe valvular and ischemic heart diseases. Arzneimittelforsch 30:386–389

    PubMed  CAS  Google Scholar 

  • Bodrogi L, Fehér T, Váradi A, Vereckey L (1980) Pharmacokinetics of pipecuronium bromide in the rat. Arzneimittelforsch 30:366–370

    PubMed  CAS  Google Scholar 

  • Boros M, Szenohradszky J, Marosi GY, Tóth J (1980) Comparative clinical study of pipecuronium bromide and pancuronium bromide. Arzneimittelforsch 30:389–393

    PubMed  CAS  Google Scholar 

  • Bowman WC (1980) A new non-depolarizing neuromuscular blocking drug. Trends Pharm Sci 3:263–266

    Article  Google Scholar 

  • Brand L (1978) Hemodynamic changes due to anesthesia using curare and curarizing agent. In: Hemodynamic changes in anesthesia, vol 3. Academic Européene d’Anesthesiolo-gie, Paris, pp 1123–1135

    Google Scholar 

  • Bunjatjan AA, Miheev VI (1980) Clinical experience with a new steroid muscle relaxant: pipecuronium bromide. Arzneimittelforsch 30:383–385

    PubMed  CAS  Google Scholar 

  • Buzello W, Agoston S (1978) Pharmacokinetics of pancuronium in patients with normal and impaired renal function. Anaesthesist 27:291–297

    PubMed  CAS  Google Scholar 

  • Coleman AJ, Downing JW, Leary WP, Moyes DG, Styles M (1972) The immediate cardiovascular effects of pancuronium alcuronium and tubocurarine in man. Anesthesia 27:415–421

    Article  CAS  Google Scholar 

  • Fahey MR, Morris RB, Miller RD, Nguyen TL, Upton RA (1981) Pharmacokinetics of Org NC 45 (Norcuron) in patients with and without renal failure. Br J Anaesth 53:1049–1054

    Article  PubMed  CAS  Google Scholar 

  • Foldes FF, Chaudry J, Ohta Y et al. (1981) The influence of stimulation parameters on the potency and reversibility of neuromuscular blocking agents. J Neural Transm 52:227–249

    Article  PubMed  CAS  Google Scholar 

  • Kárpáti E, Biró K (1980) Pharmacological study of a new competitive neuromuscular blocking steroid, pipecuronium bromide. Arzneimittelforsch 30:346–354

    PubMed  Google Scholar 

  • Kelman GR, Kennedy BR (1971) Cardiovascular effects of pancuronium in man. Br J Anaesth 43:335–356

    Article  PubMed  CAS  Google Scholar 

  • Krieg N, Crull JF, Booij LMD (1980) Relative potency of Org NC 45, pancuronium, alcuronium and tubocurarine in anesthetized man. Br J Anaesth 52:783–794

    Article  PubMed  CAS  Google Scholar 

  • McLoad K, Watson MJ, Rawlins MD (1976) Pharmacokinetics of pancuronium in patients with normal and impaired renal function. Br J Anaesth 48:341–349

    Article  Google Scholar 

  • Pulay I, Alánt O, Darvas K, Weltner J, Zétény ZS (1980) Respiration paralysing and circulatory effects of a new non-depolarizing relaxant, pipecuronium bromide, in anesthetized dogs. Arzneimittelforsch 30:358–360

    PubMed  CAS  Google Scholar 

  • Somogyi AA, Shanks CA, Triggs EJ (1976) Clinical pharmacokinetics of pancuronium bromide. Eur J Clin Pharmacol 10:367–372

    Article  PubMed  CAS  Google Scholar 

  • Somogyi AA, Shanks CA, Triggs EJ (1977) Disposition kinetics of pancuronium bromide in patients with total biliary obstruction. Br J Anaesth 49:1103–1107

    Article  PubMed  CAS  Google Scholar 

  • Stanski DR, Sneider LB (1979) Pharmacokinetics and dynamics of muscle relaxants. Anesthesiology 51:103–105

    Article  PubMed  CAS  Google Scholar 

  • Stoelting RK (1972) The hemodynamic effects of pancuronium and d-tubocurarine in anesthetized patients. Anesthesiology 36:612–618

    Article  PubMed  CAS  Google Scholar 

  • Sugrue MF, Duff N, McInderwar J (1975) On the pharmacology of Org 6368 [2β,16β-diperidino-5α-androstan-3α-ol acetate dimethobromide], a new steroidal neuromuscular blocking agent. J Pharm Pharmacol 27:721–727

    Article  PubMed  CAS  Google Scholar 

  • Szabó G, Tassonyi E (1981) Determination of pipecuronium bromide, a new non-depolarizing neuromuscular blocking agent, in human serum. Arzneimittelforsch 31:1013–1015

    PubMed  Google Scholar 

  • Tassonyi E, Szabó G (1977) Correlation entre le bloc n-m et taux serique du pancuronium. Central European Anaesthesia Congress, Genova, p 3351

    Google Scholar 

  • Tassonyi E, Szabó G (1981) Pharmakokinetische und pharmakodynamische Untersuchungen mit einem neuen steroidartigen Muskelrelaxans. In: Haid HB, Mitterschiffthaler G (eds) Zentraleuropäischer Anaesthesiekongreß 2. Springer, Berlin Heidelberg New York (Anaesthesiology and intensive care medicine, vol 140)

    Google Scholar 

  • Tassonyi E, Szabó G, Vereckey L (1980) Pharmacokinetics of pipecuronium bromide in patients with renal failure. In: Rügheimer E, Wawersik J, Zindler M (eds) 7th World congress of anaesthesiologists. Excerpta Medica, Amsterdam, p 168 (International congress series, no 533)

    Google Scholar 

  • Tassonyi E, Szabó G, Vereckey L (1981) Pharmacokinetics of pipecuronium bromide, a new non-depolarizing neuromuscular blocking agent, in humans. Arzneimittelforsch 31:1754–1756

    PubMed  CAS  Google Scholar 

  • Tuba Z (1980) Synthesis of 2β,16β-bis[4′-dimethyl-1-piperazino]-3α,17β-diacetoxy-5α-androstane di-bromide and related compounds. Arzneimittelforsch 30:342–345

    PubMed  CAS  Google Scholar 

  • Westra P, Houwertjes MC, DeLange AR, Scaf AH, Hindriks FR, Agoston S (1980) Effect of experimental cholestasis on neuromuscular blocking drugs in cats. Br J Anaesth 52:747–756

    Article  PubMed  CAS  Google Scholar 

  • Wittek L, Gecsényi M, Barna B, Hargitay Z, Adorján K (1980) Report on clinical test of pipecuronium bromide. Arzneimittelforsch 30:379–383

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Tassonyi, E., Szabó, G., Vimláti, L. (1986). Pipecuronium Bromide (Arduan). In: Kharkevich, D.A. (eds) New Neuromuscular Blocking Agents. Handbook of Experimental Pharmacology, vol 79. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70682-0_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70682-0_27

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-70684-4

  • Online ISBN: 978-3-642-70682-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics